Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 67457-887

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 67457-887). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logarithmic Scale.jpg (Image 01)

A forest plot chart displaying odds ratios with 95% confidence intervals from various studies assessing risk related to DMPA use. The x-axis is on a logarithmic scale ranging approximately from 0.6 to 7.4, with a reference line at odds ratio 1. Studies from Lee et al. (1987), Paul et al. (1989), WHO (1991), Shapiro et al. (2000), and Li et al. (2012) are shown with individual odds ratios and confidence intervals.*

FDA Label Image

Structure (Image 02)

Chemical structure diagram of Medroxyprogesterone Acetate, showing its molecular framework with labeled atoms and bonds.*

FDA Label Image

Image (Image 03)

A vertical chart illustrating pregnancy rates per 100 women per year in relation to contraceptive methods. The left axis shows pregnancy frequency from fewer than 1 to 85 or more, with an arrow indicating increasing pregnancies downward. Different birth control methods are listed on the right, grouped by effectiveness: implants, injections, intrauterine devices, and sterilization at the top with fewer pregnancies; birth control pills, skin gels, and vaginal rings in the middle; condoms and diaphragms lower; and no birth control at the bottom with the highest pregnancy rate.*

FDA Label Image

Carton 1 (Image 04)

Packaging label for Medroxyprogesterone Acetate 150 mg/mL Injectable Suspension, USP, by Mylan Institutional LLC. The label specifies it is a contraceptive injection for intramuscular use only, available in a package of 25 single-dose 1 mL vials. The design includes branding and dosage details in purple, black, and blue text on a white background.*

FDA Label Image

Carton (Image 05)

Packaging label for Medroxyprogesterone Acetate 150 mg/mL injectable suspension, USP by Mylan Institutional LLC. The label indicates it is a contraceptive injection for intramuscular use only, supplied in a 1 mL single-dose vial. Storage instructions and ingredients are provided, along with the NDC 67457-887-99.*

FDA Label Image

Vial (Image 06)

Label for Medroxyprogesterone Acetate 150 mg/mL injectable suspension, a contraceptive injection for intramuscular use, single-dose vial. The label shows the product name, strength, dosage form, route, and manufacturer as Mylan Institutional LLC, Morgantown, WV. It advises to shake vigorously before use and to see prescribing information for dosage and use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.